ECCO guidelines on therapeutics in Crohn's disease: medical treatment J Torres, S Bonovas, G Doherty, T Kucharzik, JP Gisbert, T Raine, ... Journal of Crohn's and Colitis 14, 4–22, 2020 | 1144 | 2020 |
Environmental risk factors for inflammatory bowel diseases: an umbrella review of meta-analyses D Piovani, S Danese, L Peyrin-Biroulet, GK Nikolopoulos, T Lytras, ... Gastroenterology 157, 647–659.e4, 2019 | 610 | 2019 |
ECCO guidelines on therapeutics in ulcerative colitis: medical treatment T Raine, S Bonovas, J Burisch, T Kucharzik, M Adamina, V Annese, ... Journal of Crohn's and Colitis 16, 2–17, 2022 | 486 | 2022 |
ECCO guidelines on therapeutics in Crohn’s disease: surgical treatment M Adamina, S Bonovas, T Raine, A Spinelli, J Warusavitarne, A Armuzzi, ... Journal of Crohn's and Colitis 14, 155–168, 2020 | 483 | 2020 |
Biologic therapies and risk of infection and malignancy in patients with inflammatory bowel disease: a systematic review and network meta-analysis S Bonovas, G Fiorino, M Allocca, T Lytras, GK Nikolopoulos, ... Clinical Gastroenterology and Hepatology 14, 1385–1397.e10, 2016 | 378 | 2016 |
Effectiveness of computerized decision support systems linked to electronic health records: a systematic review and meta-analysis L Moja, KH Kwag, T Lytras, L Bertizzolo, L Brandt, V Pecoraro, G Rigon, ... American Journal of Public Health 104, e12–e22, 2014 | 376 | 2014 |
Diabetes mellitus and risk of prostate cancer: a meta-analysis S Bonovas, K Filioussi, A Tsantes Diabetologia 47, 1071–1078, 2004 | 376 | 2004 |
Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis S Bonovas, V Peponis, K Filioussi Diabetic Medicine 21, 609–614, 2004 | 303 | 2004 |
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis S Minozzi, S Bonovas, T Lytras, V Pecoraro, M González-Lorenzo, ... Expert Opinion on Drug Safety 15 (sup1), 11–34, 2016 | 294 | 2016 |
Use of statins and breast cancer: a meta-analysis of seven randomized clinical trials and nine observational studies S Bonovas, K Filioussi, N Tsavaris, NM Sitaras Journal of Clinical Oncology 23, 8606–8612, 2005 | 264 | 2005 |
Biological agents for moderately to severely active ulcerative colitis. A systematic review and network meta-analysis S Danese, G Fiorino, L Peyrin-Biroulet, E Lucenteforte, G Virgili, L Moja, ... Annals of Internal Medicine 160, 704–711, 2014 | 260 | 2014 |
Safety of Janus kinase inhibitors in patients with inflammatory bowel diseases or other immune-mediated diseases: a systematic review and meta-analysis P Olivera, J Lasa, S Bonovas, S Danese, L Peyrin-Biroulet Gastroenterology 158, 1554–1573.e12, 2020 | 235 | 2020 |
Outbreak of West Nile virus infection in Greece, 2010 K Danis, A Papa, G Theocharopoulos, G Dougas, M Athanasiou, M Detsis, ... Emerging Infectious Diseases 17, 1868–1872, 2011 | 221 | 2011 |
Early predictors of clinical deterioration in a cohort of 239 patients hospitalized for Covid-19 infection in Lombardy, Italy M Cecconi, D Piovani, E Brunetta, A Aghemo, M Greco, M Ciccarelli, ... Journal of Clinical Medicine 9, 1548, 2020 | 220 | 2020 |
Statins and cancer risk: a literature-based meta-analysis and meta-regression analysis of 35 randomized controlled trials S Bonovas, K Filioussi, N Tsavaris, NM Sitaras Journal of Clinical Oncology 24, 4808–4817, 2006 | 213 | 2006 |
Autochthonous Plasmodium vivax malaria in Greece, 2011 K Danis, A Baka, A Lenglet, W Van Bortel, I Terzaki, M Tseroni, M Detsis, ... Eurosurveillance 16, pii=19993, 2011 | 204 | 2011 |
Statins and the risk of colorectal cancer: a meta-analysis of 18 studies involving more than 1.5 million patients S Bonovas, K Filioussi, CS Flordellis, NM Sitaras Journal of Clinical Oncology 25, 3462–3468, 2007 | 182 | 2007 |
Statin use and the risk of prostate cancer: a metaanalysis of 6 randomized clinical trials and 13 observational studies S Bonovas, K Filioussi, NM Sitaras International Journal of Cancer 123, 899–904, 2008 | 172 | 2008 |
The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk AE Tsantes, GK Nikolopoulos, PG Bagos, S Bonovas, P Kopterides, ... Thrombosis Research 122, 736–742, 2008 | 158 | 2008 |
Systematic review with network meta‐analysis: comparative assessment of tofacitinib and biological therapies for moderate‐to‐severe ulcerative colitis S Bonovas, T Lytras, G Nikolopoulos, L Peyrin‐Biroulet, S Danese Alimentary Pharmacology and Therapeutics 47, 454–465, 2018 | 156 | 2018 |